2026-10-19T04:50:26Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/180822026-10-18T21:13:17Zopenairedrivercom_ebyu_10000col_ebyu_10001

The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19Saygideger, YaseminBAYINDIR, YasarAzap, Alpaymete, ayşe özlemKaya, SafakAcar, AliBinay, Umut DevrimYildiz, YesimARSLAN, YUSUFKandemir, ÖzlemKADİROĞLU, Ali KemalYildirim, CigdemKalkan, İrem AkdemirAsan, Alikeskin, Ayşegül SeremetOZER, Ayse BelinMERMUTLUOĞLU, ÇİĞDEMkomur, suheylaŞENOL, ESİNOzger, H.SelcukEROL, ÇİĞDEMİNAN, OSMANAkça, Mustafa Özgürünlü, GültenKaramanlıoğlu, DilekBayram, HalimYasar, Simgetaş, zeynep tekinSakız, AyşeDiseases, The Adult Immunization Study Group of the Turkish Society of Clinical Microbiology and InfectiousHalk ve Çevre SağlığıMikrobiyolojiObjective: We aimed to investigate the vaccination status and the risk factors for the in- tensive care unit (ICU) support need of the laboratory-confirmed breakthrough COVID-19 infection inpatients. Materials and Methods: This multi-center point-prevalence study was conducted on inpa- tients, divided into two groups as ‘fully’ and ‘partially’ vaccinated according to COVID-19 vaccination status. Results: Totally 516 patients were included in the study. The median age was 65 (55-77), and 53.5% (n=276) of the patients were male. Hypertension (41.9%, n=216), diabetes mel- litus (DM) (31.8%, n=164), and coronary artery disease (CAD) (16.3%, n=84) were the pre- dominant comorbidities. Patients were divided into two groups ICU (n=196) and non-ICU (n=301). Hypertension (p=0.026), DM (p=0.048), and congestive heart failure (CHF) (p=0.005) were significantly higher in ICU patients and the median age was younger among non-ICU patients (p=0.033). Of patients, 16.9% (n=87) were fully vaccinated, and this group’s need for ICU support was statistically significantly lower (p=0.021). Conclusion: We conclude that older age, hypertension, DM, CHF, and being partially vacci- nated were associated with the need for ICU support. Therefore, all countries should con- tinuously monitor post-vaccination breakthrough COVID-19 infections to determine the national booster vaccine administration approach that will provide vulnerable individuals the highest protection.2023Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/18082https://doi.org/10.36519/idcm.2023.216enInfectious diseases and clinical microbiology (Online)info:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/18082